Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterโs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL CONTRAST MEDIA MARKET, BY TYPE
6.1. Overview
6.2. Iodinated Contrast Media
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.3. Gadolinium-based Contrast Media
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4. Microbubble Contrast Media
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.5. Barium-based Contrast Media
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7. GLOBAL CONTRAST MEDIA MARKET, BY FORM
7.1. Overview
7.2. Tablet
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.3. Powder
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.4. Liquid
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.5. Paste
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8. GLOBAL CONTRAST MEDIA MARKET, BY PROCEDURES
8.1. Overview
8.2. X-Ray/Computed Tomography (CT)
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.3. Magnetic Resonance Imaging (MRI)
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.4. Ultrasound
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9. GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION
9.1. Overview
9.2. Cardiovascular Disease
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.3. Oncology
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.4. Gastrointestinal Disorders
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.5. Neurological Disorders
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.6. Other Indications
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
10. GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION
10.1. Overview
10.2. Rectal
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
10.3. Oral
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
10.4. Injectable
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
11. GLOBAL CONTRAST MEDIA MARKET, BY REGION
11.1. Overview
11.2. Americas
11.2.1. North America
11.2.1.1. US
11.2.1.2. Canada
11.2.2. Latin America
11.3. Europe
11.3.1. Western Europe
11.3.1.1. Germany
11.3.1.2. France
11.3.1.3. Italy
11.3.1.4. Spain
11.3.1.5. UK
11.3.1.6. Rest of Western Europe
11.3.2. Eastern Europe
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia
11.4.5. South Korea
11.4.6. Rest of Asia-Pacific
11.5. Middle East & Africa
11.5.1. Middle East
11.5.2. Africa
12. COMPANY LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Global Contrast Media Market
12.5. Competitive Benchmarking
12.6. Leading Players in terms of Number of Developments in the Global Contrast Media Market
12.7. Key developments and Growth Strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix & Market Ratio
12.8.1. Sales & Operating Income 2020
12.8.2. Major Players R&D Expenditure 2020
12.9. Major Players Capital Market Ratio
13. COMPANY PROFILES
13.1. DAIICHI
13.1.1. Company Overview
13.1.2. Product Overview
13.1.3. Financial Overview
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. NANOSCAN IMAGING
13.2.1. Company Overview
13.2.2. Product Overview
13.2.3. Financial Overview
13.2.4. Key Developments
13.2.5. SWOT Analysis
13.2.6. Key Strategies
13.3. Bayer AG
13.3.1. Company Overview
13.3.2. Product Overview
13.3.3. Financial Overview
13.3.4. Key Developments
13.3.5. SWOT Analysis
13.3.6. Key Strategies
13.4. Bracco Diagnostic Inc
13.4.1. Company Overview
13.4.2. Product Overview
13.4.3. Financial Overview
13.4.4. Key Developments
13.4.5. SWOT Analysis
13.4.6. Key Strategies
13.5. GE Healthcare
13.5.1. Company Overview
13.5.2. Product Overview
13.5.3. Financial Overview
13.5.4. Key Developments
13.5.5. SWOT Analysis
13.5.6. Key Strategies
13.6. Guerbet Group
13.6.1. Company Overview
13.6.2. Product Overview
13.6.3. Financial Overview
13.6.4. Key Developments
13.6.5. SWOT Analysis
13.6.6. Key Strategies
13.7. Jodas Expoim
13.7.1. Company Overview
13.7.2. Product Overview
13.7.3. Financial Overview
13.7.4. Key Developments
13.7.5. SWOT Analysis
13.7.6. Key Strategies
13.8. Lantheus Medical Imaging Inc.
13.8.1. Company Overview
13.8.2. Product Overview
13.8.3. Financial Overview
13.8.4. Key Developments
13.8.5. SWOT Analysis
13.8.6. Key Strategies
13.9. Magnus Health
13.9.1. Company Overview
13.9.2. Product Overview
13.9.3. Financial Overview
13.9.4. Key Developments
13.9.5. SWOT Analysis
13.9.6. Key Strategies
13.10. Spago Nanomedical AB
13.10.1. Company Overview
13.10.2. Product Overview
13.10.3. Financial Overview
13.10.4. Key Developments
13.10.5. SWOT Analysis
13.10.6. Key Strategies
13.11. Taejoon Pharm
13.11.1. Company Overview
13.11.2. Product Overview
13.11.3. Financial Overview
13.11.4. Key Developments
13.11.5. SWOT Analysis
13.11.6. Key Strategies
13.12. Others
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL CONTRAST MEDIA MARKET SYNOPSIS, 2022-2030
TABLE 2 GLOBAL CONTRAST MEDIA MARKET ESTIMATES & FORECAST, 2022-2030 (USD MILLION)
TABLE 3 GLOBAL CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 4 GLOBAL CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 5 GLOBAL CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 6 GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 7 GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 8 GLOBAL CONTRAST MEDIA MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 9 NORTH AMERICA: CONTRAST MEDIA MARKE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 10 NORTH AMERICA: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 11 NORTH AMERICA: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 12 NORTH AMERICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 13 NORTH AMERICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 14 US: CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 15 US: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 16 US: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 17 US: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 18 US: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 19 CANADA: CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 20 CANADA: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 21 CANADA: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 22 CANADA: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 23 CANADA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 24 LATIN AMERICA: CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 25 LATIN AMERICA: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 26 LATIN AMERICA: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 27 LATIN AMERICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 28 LATIN AMERICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 29 EUROPE: CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 30 EUROPE: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 31 EUROPE: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 32 EUROPE: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 33 EUROPE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 34 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 35 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 36 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 37 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 38 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 39 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 40 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 41 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 42 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 43 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 44 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 45 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 46 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 47 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 48 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CONTRAST MEDIA MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CONTRAST MEDIA MARKET
FIGURE 4 GLOBAL CONTRAST MEDIA MARKET SHARE, BY TYPE, 2020 (%)
FIGURE 5 GLOBAL CONTRAST MEDIA MARKET SHARE, BY FORM, 2020 (%)
FIGURE 6 GLOBAL CONTRAST MEDIA MARKET SHARE, BY PROCEDURES, 2020 (%)
FIGURE 7 GLOBAL CONTRAST MEDIA MARKET SHARE, BY APPLICATION, 2020 (%)
FIGURE 8 GLOBAL CONTRAST MEDIA MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2020 (%)
FIGURE 9 GLOBAL CONTRAST MEDIA MARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 AMERICAS: CONTRAST MEDIA MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 NORTH AMERICA: CONTRAST MEDIA MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 EUROPE: CONTRAST MEDIA MARKET SHARE, BY REGION, 2020 (%)
FIGURE 13 WESTERN EUROPE: CONTRAST MEDIA MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 ASIA-PACIFIC: CONTRAST MEDIA MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 15 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 16 GLOBAL CONTRAST MEDIA MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 17 DAIICHI.: KEY FINANCIALS
FIGURE 18 DAIICHI: SEGMENTAL REVENUE
FIGURE 19 DAIICHI: REGIONAL REVENUE
FIGURE 20 NANOSCAN IMAGING: KEY FINANCIALS
FIGURE 21 NANOSCAN IMAGING: SEGMENTAL REVENUE
FIGURE 22 NANOSCAN IMAGING: REGIONAL REVENUE
FIGURE 23 BAYER AG: KEY FINANCIALS
FIGURE 24 BAYER AG: SEGMENTAL REVENUE
FIGURE 25 BAYER AG: REGIONAL REVENUE
FIGURE 26 BRACCO DIAGNOSTIC INC: KEY FINANCIALS
FIGURE 27 BRACCO DIAGNOSTIC INC: SEGMENTAL REVENUE
FIGURE 28 BRACCO DIAGNOSTIC INC: REGIONAL REVENUE
FIGURE 29 GE HEALTHCARE: KEY FINANCIALS
FIGURE 30 GE HEALTHCARE: SEGMENTAL REVENUE
FIGURE 31 GE HEALTHCARE: REGIONAL REVENUE
FIGURE 32 GUERBET GROUP: KEY FINANCIALS
FIGURE 33 GUERBET GROUP: SEGMENTAL REVENUE
FIGURE 34 GUERBET GROUP: REGIONAL REVENUE
FIGURE 35 JODAS EXPOIM: KEY FINANCIALS
FIGURE 36 JODAS EXPOIM: SEGMENTAL REVENUE
FIGURE 37 JODAS EXPOIM: REGIONAL REVENUE
FIGURE 38 LANTHEUS MEDICAL IMAGING INC.: KEY FINANCIALS
FIGURE 39 LANTHEUS MEDICAL IMAGING INC.: SEGMENTAL REVENUE
FIGURE 40 LANTHEUS MEDICAL IMAGING INC.: REGIONAL REVENUE
FIGURE 41 MAGNUS HEALTH: KEY FINANCIALS
FIGURE 42 MAGNUS HEALTH: SEGMENTAL REVENUE
FIGURE 43 MAGNUS HEALTH: REGIONAL REVENUE
FIGURE 44 SPAGO NANOMEDICAL AB: KEY FINANCIALS
FIGURE 45 SPAGO NANOMEDICAL AB: SEGMENTAL REVENUE
FIGURE 46 SPAGO NANOMEDICAL AB: REGIONAL REVENUE
FIGURE 47 TAEJOON PHARM: KEY FINANCIALS
FIGURE 48 TAEJOON PHARM: SEGMENTAL REVENUE
FIGURE 49 TAEJOON PHARM: REGIONAL REVENUE